Prostate Cancer
Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study.
September 18, 2024
Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy.
September 18, 2024
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.
September 18, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.
September 18, 2024
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
September 18, 2024
Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors
September 17, 2024
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes
September 17, 2024
Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment.
September 17, 2024
Ejaculatory function after radiotherapy for prostate cancer: a systematic review and meta-analysis.
September 17, 2024
Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.
September 17, 2024
Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study.
September 17, 2024
Extracellular Vesicles heterogeneity through the lens of multiomics.
September 17, 2024
Prostate cancer disparities in clinical and survival patterns among Black and Latino patients considering nativity: findings from the California Cancer Registry.
September 17, 2024